Visual Exploration of the Evolving Role of Novel Oral SERDs and More in ER+, HER2- MBC
Автор: PeerView Oncology
Загружено: 2025-09-30
Просмотров: 151
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AQV865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until September 28, 2026.
Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC
In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and METAvivor. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Lilly.
Disclosure information is available at the beginning of the video presentation.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
![[Webinar] Manufacturing concepts for antibody-drug conjugates | Webinar](https://ricktube.ru/thumbnail/2FwI79aZTCc/mqdefault.jpg)
